Author

John Armato

Observed names: John P Armato, John P. Armato

Institution: Little Company of Mary Hospital

Observed institution: Little Company of Mary Hospital

ORCID: 0000-0002-9005-7144

Observed ORCID: 0000-0002-9005-7144

OpenAlex ID: A5009601857

Successful treatment of prediabetes in clinical practice using physiological assessment (STOP DIABETES)

2018 · John P Armato, Ralph A DeFronzo, et al. · The Lancet Diabetes & Endocrinology · 70

Successful Treatment of Prediabetes in Clinical Practice: Targeting Insulin Resistance and β-Cell Dysfunction

2011 · John Armato, Ralph A. DeFronzo, et al. · Endocrine Practice · 35

Triglyceride/High-Density Lipoprotein Cholesterol Concentration Ratio Identifies Accentuated Cardio-Metabolic Risk

2015 · John Armato, Gerald Reaven, et al. · Endocrine Practice · 21

Pre-Prediabetes: Insulin Resistance Is Associated With Cardiometabolic Risk in Nonobese Patients (STOP DIABETES)

2024 · John Armato, Ralph A DeFronzo, et al. · The Journal of Clinical Endocrinology & Metabolism · 12

GLP-1 Provoked Severe Hypoglycemia in an Individual With Type 2 Diabetes and a Benign Insulinoma

2014 · Ronald J. Ruby, John P. Armato, et al. · Diabetes Care · 10

Are angiotensin‐converting enzyme inhibitors/angiotensin receptor blockers associated with reduced severe acute respiratory syndrome coronavirus 2 infections and improved outcomes, and does race matter?

2022 · John Armato, Ralph A. DeFronzo, et al. · Diabetes Obesity and Metabolism · 2

Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization ( STOP DIABETES )

2026 · John Armato, Ralph A. DeFronzo, et al. · Diabetes Obesity and Metabolism

Author response for "Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization (STOP DIABETES)"

2026 · John Armato, Ralph A. DeFronzo, et al. · Publons reviews and discussion

Author response for "Insulin Sensitive Patients With Impaired Glucose Tolerance: Physiologic and Metabolic Characterization (STOP DIABETES)"

2026 · John Armato, Ralph A. DeFronzo, et al. · Publons reviews and discussion

Author response for "Are Ambulatory ACE Inhibitors/Angiotensin Receptor Blockers Associated with Reduced SARS‐CoV ‐2 Infections and Improved Outcomes, and Does Race Matter?"

2022 · John Armato, Ralph A DeFronzo, et al. · Publons reviews and discussion

Works count: 10

Citation count: 150

H-index: 5

I10-index: 5